Antimicrobial Resistance
Carbapenem resistance is emerging in strains worldwide
Published in TB and Outbreaks Week, April 5th, 2005
According to a study from Scotland, "Acinetobacter baumannii is now one of the most frequently encountered nosocomial pathogens in intensive therapy units, and is renowned for being difficult to treat because of resistance to most antibiotics.
"Carbapenems are the remaining drugs of choice in many centers, but carbapenem resistance is now emerging in strains worldwide. Two subgroups of carbapenem-hydrolyzing beta-lactamases, which differ in their amino-acid homology, have been found in some resistant strains."
"This...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Dengue Hemorrhagic Fever
Dengue hemorrhagic fever increasing among children in northern Brazil - SARS Coronavirus
Recombinant nucleocapsid protein-based assay detects anti-SARS-CoV IgG - Sporotrichosis
Sporotrichosis diagnosis may be confounded by Leishmania coinfection - West Nile Virus
Interferon can cure cells of West Nile virus replicons - Acinetobacter Infection
Risk factors identified for multidrug-resistant A. baumannii infection - Air Monitoring
PCR method quantifies A. fumigatus conidia from environmental air samples - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
